US$ 21.13
glp-1 obesity drugs pipeline A glimpse into the of anti-obesity medication development: combining multiple receptor pathways Obesity Drug Pipeline Expands with
Description
GLP-1 analog modulates appetite, taste preference, gut hormones, and regional body fat stores in adults with obesity
New avenues in the regulation of gallbladder motility-implications for the use of glucagon-like peptide-derived drugs

Increased energy expenditure in hemodialysis patients

doi: 10.1038/s41574-018-0118-x 41 Del PratoSGallwitzBHolstJJMeierJJ

Ann Fam Med
